Literature DB >> 8154497

Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies.

L N Prieto1, W N Suki.   

Abstract

We present two cases of patients with systemic lupus erythematosus and end-stage renal disease. Both were on hemodialysis and had multiple arteriovenous graft thromboses associated with the presence of antiphospholipid antibodies. A review of patients with end-stage renal disease secondary to systemic lupus erythematosus reveals that all had borderline or frankly elevated antiphospholipid antibody titers, and four of the seven patients had multiple graft thromboses. Possible etiologic and pathophysiologic mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154497     DOI: 10.1016/s0272-6386(12)80383-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Guillermo J Pons-Estel; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 2.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

3.  Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients.

Authors:  Roozbeh Jamshid; Serati Ali Reza; Ghaderi Abbas; Afshariani Raha
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 4.  Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy.

Authors:  Maria G Tektonidou
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 5.  Renal involvement in antiphospholipid syndrome.

Authors:  Savino Sciascia; Maria José Cuadrado; Munther Khamashta; Dario Roccatello
Journal:  Nat Rev Nephrol       Date:  2014-03-18       Impact factor: 28.314

Review 6.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.